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1. Introduction 
Due to the recent increased use of diagnostic abdominal imaging and/ or serum prostate 
specific antigen (PSA) test, both incidental small renal tumors and low-risk prostate cancer 
are being detected more frequently. This leads to greater numbers of asymptomatic organ-
confined early cancers in urology. Treatment strategy needs therefore to be reassessed 
because of the lack of comparative evidence in effectiveness and the harm of current 
standard radical invasive treatments especially for such early low-risk asymptomatic 
cancers (Hollingsworth et al 2006, Wilt et al 2007). The precision of the imaging for staging and 
localization of the diseases is an important problem so that this brings patients a benefit, 
avoiding the over-diagnosis of clinically insignificant cancer (which does not need to be 
treated) as well as under-diagnosis of advanced cancers (which definitely need to be 
treated.)  As such, imaging technology is now evolving, and focal therapy for prostate and 
kidney cancer has attracted attention in urology (Gill et al 2010, Eggener et al 2007).  Focal 
therapy aims to achieve targeted control or cure of the malignancy as well as preservation of 
organ function in order to maintain the QOL of individual patients.   
Looking back on the history of urology, there was a definite step when urologists began to 
practise transurethral resection of bladder tumors (TUR-Bt), and this can be clearly categorised 
as a type of minimally invasive focal therapy.  TUR-Bt can achieve the clinical control or cure 
of superficial bladder cancer as well as preservation of the bladder in order to maintain QOL, 
while allowing the patient to urinate through his or her own urethra, avoiding problematic 
urinary stoma on the abdominal skin.  Such focal therapy can be performed generally in the 
out-patient day surgery, and is also repeatable at a certain interval if indicated. Should the 
disease become upgraded or upstaged during active surveillance after such focal therapy, the 
patients would reasonably accept radical treatment when indicated later.  
On the other hand, historically we also find shared critical opinion against focal therapy in 
prostate cancer for 3 main reasons in recent years: firstly, the technological therapeutic 
difficulty of focal treatment; secondly, the lack of reliable imaging to localize and 
characterize potentially multifocal and multi-grade prostate cancers; and thirdly, the 
immaturity of navigation technology to achieve precise 3-dimensional targeting to the 
biopsy-proven cancer lesion.    
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However, with increased knowledge of the natural history of prostate cancer, it is now 
discussed that the prognostic importance of the index prostate cancer, which is a cancer 
with the highest grade and largest volume in an individual prostate and must determine the 
individual prognosis of the disease. As such, the important hypothesis has arisen that we 
might be able to achieve reasonable oncological control by focal therapy, targeting the 
index-lesion at least, while preserving the healthy parts of the prostate and peri-prostatic 
tissue that contribute to maintaining urinary continence and sexual function. This would be 
recommended for patients who are reluctant to accept active surveillance or conservative 
treatment (Eggener et al, 2007).    
The current therapeutic standard for clinical localized renal cancer is surgical removal, 
preferably in the form of nephron-sparing surgery, supported by durable oncological 
outcomes and overall survival, while active surveillance and minimally invasive ablative 
techniques have emerged as potential alternatives in carefully selected patients (Gill et al, 
2010).   
Accordingly, for both kidney and prostate cancers, we are facing a real challenge towards 
endoscopic robotic-assisted surgery, focal ablative therapy, and further computer-assisted, 
minimally invasive ablation (such as cryosurgery, laser therapy, radiofrequency ablation), or 
extra-corporeal therapy (such as high-intensity focused ultrasound). A reliable image 
navigation system would become an essential tool, to facilitate realization of where the 
surgical pathological targets and vital healthy anatomies are located in the surgical field 
beyond the surgeon’s direct vision or underneath the palpable anatomies.  Image-navigation 
would help intra-operative appropriate decision-making before surgical exposure of the 
target has even been made, to minimize any iatrogenic injury to the surrounding healthy 
tissues, and to lead to precise surgical dissection or appropriate delivery of the ablative 
energy to the surgical target while preserving safe surgical margins. Real-time anatomical 
and pathological visualization is required for intra-operative navigation, although there 
may be no perfect single imaging modality to achieve this image-navigation mission.  In 
addition, instead of free-hand control, computer-assistance and robotic control of the 
surgical instruments or interventional probes could increase procedural accuracy while 
potentially decreasing the learning curve. “Image-fusion”  integrated with such computer-
assistance and robotic control would become the key technology.   
Active surveillance could increasingly become an important option for the management of 
low risk kidney and prostate cancers. The optimal biopsy protocol is still controversial in 
both kidney and prostate, and a new reliable biopsy protocol should be considered since the 
pathological evidence given by needle biopsy specimens could be one of the key 
components for determining the oncologic management of these organs.    
To obtain reliable information from biopsy sampling, precise spatial targeting accuracy is 
critical. Since CT-guidance and MR-guidance require expensive facilities and significant 
expertise in intervention, image-fusion guidance, such as real-time US fusion with 
previously acquired enhanced CT for the kidney and enhanced MR for the prostate, would 
provide a clinically relevant opportunity for urologists. The recently emerging technology of 
“ image-fusion” in urology includes the spatial tracking system of a 2D US probe or 
interventional needle with attached electromagnetic and/ or optical sensors or with robotic 
control. Another technology involves the acquisition of real-time 3D volume data in order to 
track with more reality in the spatial targeted fields. This article intends to discuss the 
advantages and limitations in the current proposed techniques of “ image fusion”  in biopsy, 
intervention, and surgery in urology.   
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Among the various image-guided procedures in urology, percutaneous 
drainage/ aspiration, percutaneous nephrostomy, percutaneous renal biopsy or renal 
ablative therapy (for placement of a cryo-surgery probe or radiofrequency probe), 
transrectal/ transperineal prostate biopsy, and transperineal cryo-surgery or brachytherapy 
for prostate cancer could be listed as clinically frequent in diagnostic and interventional 
procedures.   Image-guidance in urology could be performed by an urologist with expertise 
in imaging, but has frequently been performed with the help of an uro-radiologist. The 
choice of the imaging modality for kidney intervention has been based on the preference of 
the physicians. For prostate intervention, transrectal ultrasound (TRUS) has been the gold 
standard as the guidance tool for prostate biopsy delivery. However, controversial issues 
continue due to a current misjudgment of the true value of TRUS as well as emerging MR 
technology. 
2. Percutaneous renal intervention 
Percutaneous imaging guided biopsy and tumor ablation has an increasingly prominent role 
as minimally invasive management for renal tumors. Precise biopsy needle and ablative 
probe placement as well as safe and effective ablation are key steps for successful 
management. In renal intervention such as in the development of neprostomy, investigators, 
especially in the USA, considered fluoroscopy as an essential tool for guide-wire 
introduction, nephrostomy tract dilation, and nephrostomy tube placement (Barbaric et al 
1984, Ko et al 2008). Others, especially in Europe and Japan, have preferred ultrasound 
guidance during puncture of the renal collecting system (Saitoh e al 1982, Skolarikos et al, 
2005). Most often many current investigators now understand the advantages in combining 
the use of these 2 real-time imaging modalities for renal puncture.  Since the pathologic fluid 
collection or renal collecting system are generally dilated to >10 mm, such a dilated 
collection system can be targeted so easily that image-guidance at this setting may not 
require very detailed anatomical signal/ noise ratio or imaging expertise. On the other hand, 
in order to achieve precise targeting of a small renal mass, renal tumor biopsy and tumor 
ablative therapy are most often guided by CT fluoroscopy (Remzi e al 2009, Leveridge et al 
2010), although it may be also precisely guided under US-guidance if performed by US 
experts (Atwell et al 2007, Bassignani et al 2004). Although US visualization of the kidney is 
excellent, the major disadvantages of US-guidance include the requirement of significant 
experience in interpretation of the peri-renal anatomy and vasculatures, difficulty of 
obtaining high-quality images in obese patients, and the difficulty in access of the upper-
pole where the US-beam is blocked by the 11th and 12th rib-bones. The major disadvantage of 
CT fluoroscopy is the radiation exposure for both patients and physicians, and almost all of 
these CT-guided procedures were performed by radiologists because of its availability.  In 
addition, since percutaneous CT-guided intervention generally uses un-enhanced CT 
images, intra-renal tumor margins are often hardly identified. Similarly, although the recent 
introduction of real-time MR is a promising tool, there is also the considerable issue in the 
availability of such expensive MR-compatible instruments and facilities. As such, pioneer 
experience of image-guided percutanous renal intervention required considerable expertise 
with such high-resolution imaging, and the limited availability of the expensive imaging 
modality was the significant issue for urologists.   There is no doubt that enhanced CT is the 
most reliable, standard imaging for the diagnosis of renal mass. However, enhanced 
visualization of the renal tumor is dynamically transient. It does not continue long enough 
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to be useful during entire interventional real-time procedures, and importantly, it can not be 
repeated often since the contrast enhancer is harmful to the renal function.     
As such, to my best knowledge, the most promising solution for overcoming both the 
technical difficulties and the lack of availability of enhanced CT imaging is to use image-
fusion of real-time imaging with pre-operatively acquired enhanced CT volume data, which 
can be integrated with a needle/ probe tracking system by GPS(global positioning system)-
like technology. Recently, various image-fusion guided techniques have been proposed, 
which are undergoing research to demonstrate their technical feasibility in preliminary 
clinical studies (Ukimura & Gill 2008, Ukimura & Gill 2009, Haber et al 2010). However, it may 
be still challenging to achieve clinically relevant accuracy in image-registration as well as in 
needle/ probe placement, which has to be available during the limited computation time, 
taking into account each patient’s deformable anatomies during the real-surgical 
procedures.   
In 2002, Leroy et al reported a pioneer work on the registration of kidney contours by CT 
and US images, and also investigated the automated voxel based registration of CT with 3D 
US, achieving 3.1 mm in registration accuracy, although requiring 80 sec. in computation 
time (Leroy et al 2002, Leroy et al and 2004).  In 2004, Osorio et al presented augmented reality 
visualization that allowed projection of pre-operative CT onto the patient’s body, although 
this system does not achieve real-time monitoring of the procedure (Osorio et al 2004). In 
2005, Mozer et al evaluated the accuracy of the fusion of CT with real-time US for 
percutaneous renal access, reporting the encouraging registration accuracy of 4.7 mm 
between planned and reached targets (Mozer et al 2005).  They noted that error was mainly 
due to needle deflection during puncture.    
For precise needle/ probe placement, a GPS-like technique for navigation of the needle tract 
would be ideal in combination with image-fusion guidance. For this purpose, investigators 
have used an infrared optical tracking system, to track optical sensors which were located 3-
dimensionally, and a tracking handle for guidance of the cryoprobe placement (Haber et al 
2010). Similarly, a magnetic sensor mounted radio-frequency ablative probe can be used for 
real-time surgical planning to overlay 3D data of the theoretical therapeutic area onto the 
registered 3D volume of the CT which was pre-registered with real-time US images (Crocetti 
et al 2008).   
In the fusion of two imaging modalities, image-registration has been classified as “rigid 
registration”  or “non-rigid registration” . Since the urological organs are often shifted by 
respiration or deformed by surgical manipulation, rigid registration may not be a 
sufficiently precise image-fusion for routine clinical use in urology. Recent efforts in non-
rigid registration between pre-operative high-resolution imaging and real-time imaging 
potentially provide a new powerful opportunity to take into account the deformation of the 
organs in image-fusion guided intervention or surgery. 
Wein et al reported a non-rigid registration for the image fusion of pre-operative contrast 
enhanced CT with intra-operative US images at the time of renal biopsy and radio-
frequency-ablation, to achieve a fiducial registration error of 5 mm (Wein et al 2008).  More 
recently, Oguro et al have proven that a non-rigid registration technique (fiducial 
registration error of 1.7 mm) was more accurate than a rigid registration technique (fiducial 
registration error of 5 mm) when fusing pre-procedural contrast-enhanced MR images to 
unenhanced CT images during CT-guided percutaneous cryoablation of renal tumors 
(Oguro et al 2010).  The non-rigid registration technique promises to improve visualization of 
renal tumors using pre-procedural enhanced imaging during unenhanced CT-guided 
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cryoablation procedures, although current limitation of the highly precise non-rigid 
registration does require the significantly long time of 15 minutes to perform.  Further 
technological improvements are being investigated. 
3. Augmented reality in surgical navigation 
Soft tissue navigation systems in urologic surgery are evolving. The augmented reality 
surgical navigation technique has been most widely used in the field of neurosurgery (Iseki 
et al 1997, Kawamata et al 2002), in which there is a clear advantage of minimum organ 
motion in a relatively fixed surgical field within a bony frame, facilitating the registration of 
the 3D image data. Augmented reality for the management of intra-abdominal soft organs 
was challenging (Marescaux et al 2004, Osorio et al 2004, Ukimura & Gill 2007), because intra-
abdominal organs may suffer more from respiratory motion or deformation by 
manipulation.  
Ukimura and colleagues have demonstrated the feasibility of augmented reality in 
laparoscopic surgery for partial nephrectomy and prostatectomy, using optical tracking 
systems of the dynamic motion of the surgical instruments, with computer-assisted 
synchronization of the developed 3D image from the 3D volume data of enhanced CT or 
intra-operatively acquired 3D volume data of transrectal ultrasound images (Ukimura & Gill 
2007, Ukimura & Gill 2008, Ukimura & Gill 2009).  The approach is technically feasible, but 
many issues need to be resolved before its clinical wide-spread use in the fields of surgery 
dealing with soft tissue organs. Nevertheless, recent advancement in augmented reality in 
urological surgery deserves attention.    
Su et al. described a stereo-endoscopic visualization system for augmented reality overlay 
during robot assisted laparoscopic partial nephrectomy. The stereoscopic system allows the 
3D-to-3D registration system of the preoperative CT scan without external tracking devices, 
using image-based surface tracking technology to track gross movement, with an update 
rate of 10 Hz and an overlay latency of four frames to place a reconstructed 3D CT image 
onto the stereo video footage (Su et al 2009). Teber et al. reported an augmented reality 
assisted soft-tissue navigation system using a mobile C-Arm capable of cone-beam imaging, 
which required the surgeon to insert four or more needle-shaped navigation aids into the 
target organ (Teber et al 2009). Herrell et al. demonstrated an augmented reality guided 
laparoscopic procedure using tissue mimicking phantoms, to compare their named 
‘resection ratio’, that was defined as the ratio of dissected tissue compared to the ideal 
resection, between with and without augmented reality image guidance (Herrel et al 2009). 
The resection ratio (3.26) in using image guidance was significantly smaller than that (9.01) 
in using no image guidance, potentially leading to a decrease of benign tissue removal while 
maintaining an appropriate surgical margin. 
The challenge continues in the real-time tracking of organ motion and deformation, to 
achieve real-time dynamic navigation through an ongoing surgical procedure. In particular,  
conventional optical tracking systems and wired magnetic tracking systems are not suitable 
for tracking internal organ motion. An emerging technology, named the Calypso 4-D 
localization system (calypso Medical Technologies, Inc., Seattle, WA, USA), is a miniature, 
wireless magnetic tracking system, which was applied to tracking the prostate motion 
during external radiotherapy (Kupelian et al 2007). We have applied this new technology for 
an endoscopic augmented reality system to demonstrate real-time dynamic superimposition 
of the pre-operatively acquired CT image onto the endoscopic image of the moving organ 
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during advancing surgical manipulation (Nakamoto et al 2008, Ukimura & Gill 2009). Such 
augmented reality image navigation with a 4D-dynamic organ tracking system, being 
integrated with robotic controlled surgical systems, is likely to herald higher precision 
surgery in the near future. 
4. Image-fusion for radiotherapy, prostate biopsy, and lesion-targeted 
prostate intervention 
Pioneer works in the image-fusion of prostate imaging were reported in the field of 
radiotherapy including external beam radiation therapy and brachytherapy, using fusions of 
CT, MR, ultrasound, and/ or fluoroscopy (Holupka et al 1996, Lau et al 1996, Kagawa et al 1997, 
Amdur et al 1999, Reynier et al 2004, Daanen et al 2006, Su et al 2007). In addition, the potential 
value of image fusion of Doppler TRUS with MRI in the staging of prostatic cancer was 
discussed (Selli et al 2007). However, recent attention to image fusion technology for prostate 
cancer is more toward its value in improving the quality of prostate biopsy by precisely 
targeting the image-suspicious area, in mapping the 3D localization of biopsy-proven 
prostate cancer, as well as its value in navigating image-guided focal therapy  
(Ukimura 2010).   
Real-time TRUS has been the gold standard of prostate biopsy guidance, and therapeutic 
intervention, because of the advantages of its real-time nature, its easy-handling, the fact 
that it is urologist-friendly, its relatively inexpensiveness, and its non-invasiveness.  
However, the current role of 2D real-time TRUS imaging to visualize the prostate anatomy 
as a simple delivery tool of biopsy rarely provides information on the spatial location of 
prostate cancer. On the other hand, diagnostic multi-function MRI for the prostate has 
achieved increasingly higher levels of accuracy in detection and localization of cancer in its 
3D volume data (Kirkham et al 2006, Villers et al 2006, Yakara et al 2010). However, since real-
time MR-guided targeted biopsy is still a complicated and expensive procedure, there is 
considerable interest in a technique of MR/  TRUS hybridized image-guided biopsy.    
Reported rigid MR/ TRUS fusion techniques (Kaplan et al 2002, Xu et al 2007, Singh et al 2008, 
Turkbey et al 2010) had a limitation when deformation occurred between MR and TRUS.   
Importantly, because the 3-D shapes of the prostate at the time of image-acquisition at 
preoperative MRI are likely to be different from the intra-operative TRUS images, the 
precise registration of each 3-D volume data is critical. In order to reduce the potential errors 
in rigid registration of TRUS with MRI, one solution may include preoperative MR images 
being obtained while a plastic outer-frame, of exactly the same shape as the real TRUS 
probe, is placed in the rectum, in order to simulate the deformation of the prostate caused 
by the absence or presence of a TRUS probe during the acquisition of MR or TRUS images 
(Ukimura 2010). For another potential solution, Hu and colleagues described a technique 
using a patient specific model of MR/ TRUS deformation built from simulated data for 
image-registration (Hu et al 2009). A more attractive developed technique for improvement 
of registration in MR/ TRUS image-fusion is the introduction of automatic, non-rigid 
(elastic) registration technology (Baumann et al, 2009, Martin et al 2010). This new elastic 
fusion technique allows making automatic segmentation of the prostate in TRUS images by 
deforming a patient specific 3D model built from MR image to TRUS data.  
As mentioned already, unfortunately, clinical urologists generally use TRUS only as a 
simple delivery system for systematic sextant biopsies toward the planned segmental 
locations, with no detailed 3D anatomical records of the sampled localization, and by just 
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naming the biopsy sample with a rough sextant site for review.  Since urologists often need 
repeat biopsies, this led to the current trend of taking an increased number of initial 
biopsies, and also to the risk of delivering the repeat biopsy needle to spots that have 
previously been shown to be negative for cancer, and of failing to make the necessary 
deliveries for previously un-sampled locations. In order to facilitate the emerging strategy of 
focal therapy for prostate cancer which may require precise 3D mapping of biopsy-proven 
cancer, individual recording of the 3D localization of each biopsy would be the key issue.   
As such, transperineal template grid-based 3D mapping biopsy has been proposed (Barzell 
& Melamed 2007, Onik et al 2009). However, current ongoing transperineal template 3D 
mapping biopsy may require 5-mm grid based techniques to detect clinically significant 
cancer, resulting in a tremendous number of required biopsies, for example, over 100 
samples in a large prostate. We are hoping that the improved image-fusion technique of MR 
and TRUS, and the elastic fusion of 3D real-time TRUS for 3D biopsy mapping techniques 
(Mozer et al 2009, Ukimura 2010) could improve the clinically relevant strategy for prostate 
biopsy, and also the image-guided management of prostate cancer in the near future.  
5. Molecular and radionuclide imaging for urology 
Targeted radionuclide therapy offers potential determination of targeted cancer specific 
accumulation by molecular imaging with single photon computed tomography (SPECT) or 
positron emission tomography (PET). In this decade, computer-assisted integration of 
anatomical and functional images has been demonstrated as a hybrid of PET/ CT 
[Townsend, 2001] as well as a fusion of SPECT/ CT (Schillaci et al 2005), providing us a new 
opportunity of interpretation of side-by-side or overlaid dual modalities. Cancer specific 
molecular imaging and radionuclide therapy is attractive for the early detection and staging 
of malignancies, and for the precise selection of patients who would benefit from molecular-
based targeted therapy and monitoring.     
18F-FDP (fluorodeoxyglucose) PET/ CT has been widely used in the management of various 
malignancies showing an increase of glucose metabolism leading to uptake of 18F-FDP, 
although the urinary excretion of 18F-FDP and relatively low uptake of 18F-FDP especially 
in small sized foci (<5mm) of prostate cancer and some types of renal cancer were a clear 
limitation of its expansion in urology. At the same time, other PET tracers have recently 
demonstrated improved accuracy of PET/ CT, which include 11C-choline, 18F-fluorocholine, 
11C-acetate, and 18F- fluoride that might correlate to prognosis and localization in prostate 
cancer (Wachter et al 2007, Bouchelouche& Oehr J Urol 2008, Piert et al 2009, Poulsen et al 2010).   
The fusion image of SPECT with CT might also improve the role of imaging in the diagnosis 
and therapy of prostate caner (Krengli et al 2006, Sodee et al 2007). The usefulness of 
pretreatment 111-Indium capromab pendetide radio-immuno-scintigraphy plus SPECT co-
registration with CT scans has been demonstrated in detection of occult metastatic disease 
and predicting for biochemical failure in patients who had evidence of that possibility after 
radiotherapy (Ellis et al 2008). This image-fusion capability leads to a new proposed strategy 
for image-guided radiation therapy to favor dose-escalation to the regions as defined by 
focal uptake on radio-immuno-scintigraphy fusion with anatomical image sets (CT or MRI) 
(Ellis & Kaminsky 2006). 
However, there is still challenge in molecular-based diagnosis and radionuclide therapy for 
clinically personalized use, which requires improved detection and efficacy in large clinical 
trials. 
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6. Conclusions 
Image-fusion technology would improve detection of urological malignancies and precision 
of intervention in minimally invasive urology, and are now increasingly under research for 
biopsy needle guidance and therapeutic navigation. In particular, the non-rigid image 
fusion of real-time US with contrast-enhanced CT/ MR, 3-dimensional mapping of biopsy 
localization, 3-dimensional image-guided lesion-targeted ablation therapy, augmented 
reality, and tumor-specific diagnostic imaging have been attracting increased attention. 
7. Figure legends 
 
Fig. 1. Augmented reality during laparoscopic nerve-sparing radical prostatectomy 
The biopsy-proven cancer area (blue), built from intra-operatively acquired 3D TRUS image, 
was overlaid on the real-time laparoscopic image during laparoscopic nerve-sparing radical 
prostatectomy 
 
 
Fig. 2. Augmented reality during laparoscopic partial nephrectomy 
The color-coded zonal anatomy (tumor by red, 0-5 mm margin by yeallow, 5-10 mm margin 
by green, beyond 10mm margin by blue), built from pre-operative contrast enhanced CT 
image, was overlaid on the real-time laparoscopic image during laparoscopic partial 
nephrectomy 
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Fig. 3. 4D Augmented reality navigation  
Using body-GPS (left, Calypso miniature wireless magnetic tracking system) to track real-
timely the motion of the organ, 3D model of pre-operative CT was real-timely overlaid onto 
the laparoscopic view during ongoing surgical manipulation (middle, overlaid image at the 
initial position of the tumor) (right, real-timely overlaid image on the lifted-up tumor with 
safe surgical margin) 
 
 
Fig. 4. MR/ TRUS fusion image-guided biopsy with overlaid images of each biopsy 
trajectory 
Left, positive cancer biopsy trajectory overlaid on the MR-visible lesion (low intensity lesion 
on T2 image) 
Middle, overlaid images of each biopsy trajectory on the 3D MR image 
Right, overlaid images of each biopsy trajectory on the 3D TRUS image 
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